• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY SYNERGY¿; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY SYNERGY¿; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number H7493926216250
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Cardiac Enzyme Elevation (1838); Myocardial Infarction (1969); Occlusion (1984); ST Segment Elevation (2059); Ventricular Tachycardia (2132)
Event Date 10/18/2016
Event Type  Injury  
Manufacturer Narrative
Device is a combination product.Device evaluated by manufacturer: it is indicated that the device will not be returned for evaluation; therefore a failure analysis of the complaint device could not be completed.A review of the batch history, historical trending, and similar complaint trending review for the product family will be conducted.If there is any further relevant information from that review, a supplemental medwatch will be filed.(b)(4).
 
Event Description
(b)(6) study.It was reported that post a stenting treatment procedure, the patient experienced myocardial infarction and ventricular tachycardia.In (b)(6) 2016 the patient presented with stable angina (ccs classification-2) and was further referred for cardiac catheterization.On the same day, the index procedure was performed.Target lesion #1 was located in the mid right coronary artery (rca) (cass site #2) with 75% stenosis and was 8 mm long with a reference vessel diameter of 3.5 mm.Target lesion #1 was treated with direct placement of a 3.50 x 12 mm study stent with 0% residual stenosis.Target lesion #2 was located in the mid left anterior descending artery (lad) (cass site #13) with 85% stenosis and was 12 mm long with a reference vessel diameter of 2.5 mm.Target lesion #2 was treated with pre-dilatation and placement of a 2.50 x 16 mm study stent.Following post dilatation, residual stenosis was 0%.Two hours post index procedure, the subject was noted to have non-persistent ventricular tachycardia, with thoracic complaints and electrocardiogram (ecg) revealed temporary st segment elevations.The subject was further recommended for repeat angiography.Coronary angiography revealed good outcome in the lesion treated.However, small occlusion in the second diagonal branch originating from the stent that is deployed in mid lad and moderate grade stenosis in the transitional area from the mid to distal lad were noted.Intervention was not required in either of the cases.On the same day, the non-persistent ventricular tachycardia was considered by the hospital to be resolved.One day later, cardiac enzyme levels were noted to be elevated and the myocardial infarction was considered by the hospital to be resolved.Three days post index procedure, the subject was discharged on aspirin and clopidogrel.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY¿
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key6185112
MDR Text Key62703574
Report Number2134265-2016-11860
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
PMA/PMN Number
SIMILAR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 12/01/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/19/2017
Device Model NumberH7493926216250
Device Catalogue Number39262-1625
Device Lot Number19321140
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/01/2016
Initial Date FDA Received12/19/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/16/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age76 YR
-
-